Berenberg hikes target price on Hiscox following ‘strong’ end to trading year

by | Mar 9, 2023

Analysts at Berenberg raised their target price on insurer Hiscox from 1,015.0p to 1,285.0p on Thursday, citing a “strong finish to a turbulent year”.
Berenberg said Hiscox had a strong end to the year, with the group posting a combined ratio of 90.6% – boosted by $239.0m of reserve releases, which helped drive a 25% increase in underwriting income of roughly $270.0m year-on-year.

The German bank stated this was “a strong result” considering 2022 was “a volatile year”, with Hiscox absorbing approximately $183.0m of large loses.

Looking ahead, Berenberg said the outlook remains “very attractive”, not only for Hiscox, but for all London Market peers, as rate momentum across property and speciality reinsurance lines was expected to persist, while underwriting conditions were said to perhaps be the best in decades.

“We reduce our group FY 2023-24E GWP and NWP forecasts by 4.9-4.7% and 1.6-2.2% respectively due lower growth in retail. We improve our group FY 2023-24E combined ratio forecasts by 1ppt and 0.5ppt, respectively, due to the better expected profitability across the big ticket lines,” said Berenberg, which reiterated its ‘hold’ rating on the stock.

“We raise our investment income estimates due to the higher yields. All in all, our pre-tax profit estimates for FY 2023-24E increase by 3.6-3.4%. We roll forward our estimates one year and raise our price target to 1,285.0p.”

Reporting by Iain Gilbert at Sharecast.com

Related articles

RBC Capital cuts Rentokil price target

RBC Capital cuts Rentokil price target

(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!

x